These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 17692573)

  • 1. Accidental overdosage of levetiracetam in two children caused no side effects.
    Awaad Y
    Epilepsy Behav; 2007 Sep; 11(2):247. PubMed ID: 17692573
    [No Abstract]   [Full Text] [Related]  

  • 2. Nonepileptic seizures under levetiracetam therapy.
    Ignatenco A; Arzy S; Ghika J; Genoud D; Kaplan PW; Groppa S; Seeck M
    Epilepsy Behav; 2010 Nov; 19(3):526-7. PubMed ID: 20934390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Add-on levetiracetam in children and adolescents with refractory epilepsy: results of an open-label multi-centre study.
    Callenbach PM; Arts WF; ten Houten R; Augustijn P; Gunning WB; Peeters EA; Weber AM; Stroink H; Geerts Y; Geerts AT; Brouwer OF
    Eur J Paediatr Neurol; 2008 Jul; 12(4):321-7. PubMed ID: 17950011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levetiracetam for seizures in children with brain tumors and other cancers.
    Partap S; Fisher PG
    Pediatr Blood Cancer; 2009 Feb; 52(2):288-9. PubMed ID: 18831033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of intravenous levetiracetam in acute seizure management of children.
    Kirmani BF; Crisp ED; Kayani S; Rajab H
    Pediatr Neurol; 2009 Jul; 41(1):37-9. PubMed ID: 19520272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levetiracetam induced interstitial nephritis and renal failure.
    Hurwitz KA; Ingulli EG; Krous HF
    Pediatr Neurol; 2009 Jul; 41(1):57-8. PubMed ID: 19520278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levetiracetam in continuous spike waves during slow-wave sleep syndrome.
    Wang SB; Weng WC; Fan PC; Lee WT
    Pediatr Neurol; 2008 Aug; 39(2):85-90. PubMed ID: 18639750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generic substitution of levetiracetam resulting in increased incidence of breakthrough seizures.
    Fitzgerald CL; Jacobson MP
    Ann Pharmacother; 2011 May; 45(5):e27. PubMed ID: 21521860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolerability and dosing experience of intravenous levetiracetam in children and infants.
    Michaelides C; Thibert RL; Shapiro MJ; Kinirons P; John T; Manchharam D; Thiele EA
    Epilepsy Res; 2008 Oct; 81(2-3):143-7. PubMed ID: 18571898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjunctive levetiracetam in infants and young children with refractory partial-onset seizures.
    Piña-Garza JE; Nordli DR; Rating D; Yang H; Schiemann-Delgado J; Duncan B;
    Epilepsia; 2009 May; 50(5):1141-9. PubMed ID: 19243423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficacy and psychiatric adverse events as short-term adjunctive levetiracetam for epileptic children with refractory convulsive seizures].
    Iyoda K; Ogawa K; Okazaki T
    No To Hattatsu; 2013 Nov; 45(6):463-4. PubMed ID: 24313008
    [No Abstract]   [Full Text] [Related]  

  • 12. Levetiracetam versus carbamazepine monotherapy for partial epilepsy in children less than 16 years of age.
    Perry S; Holt P; Benatar M
    J Child Neurol; 2008 May; 23(5):515-9. PubMed ID: 18182645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levetiracetam in absence epilepsy.
    Verrotti A; Cerminara C; Domizio S; Mohn A; Franzoni E; Coppola G; Zamponi N; Parisi P; Iannetti P; Curatolo P
    Dev Med Child Neurol; 2008 Nov; 50(11):850-3. PubMed ID: 18808424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased levetiracetam clearance in pregnancy: is seizure frequency affected?
    Hoeritzauer I; Mawhinney E; Irwin B; Hunt SJ; Morrow J; Craig J
    Seizure; 2012 Sep; 21(7):559-60. PubMed ID: 22658454
    [No Abstract]   [Full Text] [Related]  

  • 15. Neurocognitive effects of adjunctive levetiracetam in children with partial-onset seizures: a randomized, double-blind, placebo-controlled, noninferiority trial.
    Levisohn PM; Mintz M; Hunter SJ; Yang H; Jones J;
    Epilepsia; 2009 Nov; 50(11):2377-89. PubMed ID: 19702752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Remember Keppra: seizure control with subcutaneous levetiracetam infusion.
    Murray-Brown FL; Stewart A
    BMJ Support Palliat Care; 2016 Mar; 6(1):12-3. PubMed ID: 26811092
    [No Abstract]   [Full Text] [Related]  

  • 17. Off-label use of antiepileptic drugs for the treatment of neonatal seizures.
    Silverstein FS; Ferriero DM
    Pediatr Neurol; 2008 Aug; 39(2):77-9. PubMed ID: 18639748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pilot study transitioning children onto levetiracetam monotherapy to improve language dysfunction associated with benign rolandic epilepsy.
    Kossoff EH; Los JG; Boatman DF
    Epilepsy Behav; 2007 Dec; 11(4):514-7. PubMed ID: 17936689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response to "Response to Zhang et al.: Levetiracetam vs. brivaracetam for adults with refractory focal seizures: A meta-analysis and indirect comparison".
    Lin Z; Xiaoyi Z
    Seizure; 2016 Oct; 41():184-6. PubMed ID: 27554810
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment with levetiracetam in a patient with pervasive developmental disorders, severe intellectual disability, self-injurious behavior, and seizures: a case report.
    Deriaz N; Willi JP; Orihuela-Flores M; Galli Carminati G; Ratib O
    Neurocase; 2012; 18(5):386-91. PubMed ID: 22059937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.